All companies
Visit website
Fluo Labs
OperatingFluo Labs, Inc.
Healthcare · Biotech · Founded 2020
A breakthrough in allergy symptom relief
Post-money valuation ⓘ
$1.3M
As of Oct 2021 · from Fluo Labs Common Stock 1 · pre-money + amount raised, not a traded price
Total raised
$82,346
Across 1 round since 2021
Latest share price
$1.00
Fluo Labs Common Stock 1 offering price
Financials
FY2019–FY2020 · from SEC filings · hover any figure for its source$0
2019
$0
−$220K
2020
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2019
FY2020
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
$0
-$220,043
Taxes paid
$0
$800
Balance sheet
Cash
$0
$1,131
Accounts receivable
$0
$0
Total assets
$0
$234,202
Short-term debt
$0
$165,505
Long-term debt
$0
$68,697
Total liabilities
$0
$234,202
Other
Headcount
—
5
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$1.3M
post-money
Fluo Labs Common Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $82.3K / $3.8MInvestors 109Post-money $1.3M
Reg CF annual-report compliance
Not obligated
never closed a Reg CF raise
109 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001868310Share price $1.00
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.